{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:35:34Z","timestamp":1769506534733,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/08711-3 and 2017\/25588-1"],"award-info":[{"award-number":["2013\/08711-3 and 2017\/25588-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013275","name":"Serrapilheira Institute","doi-asserted-by":"crossref","award":["Serra-1709-16349"],"award-info":[{"award-number":["Serra-1709-16349"]}],"id":[{"id":"10.13039\/501100013275","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302453\/2017-2"],"award-info":[{"award-number":["302453\/2017-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00406-019-01002-3","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T13:03:54Z","timestamp":1554123834000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A proteomic signature associated to atypical antipsychotic response in schizophrenia patients: a pilot study"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-5846","authenticated-orcid":false,"given":"Daniel","family":"Martins-de-Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2010.05.025","volume":"122","author":"R Tandon","year":"2010","unstructured":"Tandon R (2010) Schizophrenia, \u201cjust the facts\u201d 5. Treatment and prevention. Past, present, and future. Schizophr Res 122:1\u201323. \nhttps:\/\/doi.org\/10.1016\/j.schres.2010.05.025","journal-title":"Schizophr Res"},{"issue":"Suppl 1","key":"1002_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4088\/JCP.10075su1.01","volume":"72","author":"R Tandon","year":"2011","unstructured":"Tandon R (2011) Antipsychotics in the treatment of schizophrenia: an overview. J Clin Psychiatry 72(Suppl 1):4\u20138. \nhttps:\/\/doi.org\/10.4088\/JCP.10075su1.01","journal-title":"J Clin Psychiatry"},{"key":"1002_CR3","doi-asserted-by":"publisher","first-page":"15050","DOI":"10.1038\/npjschz.2015.50","volume":"1","author":"D Martins-de-Souza","year":"2015","unstructured":"Martins-de-Souza D, Solari FA, Guest PC et al (2015) Biological pathways modulated by antipsychotics in the blood plasma of schizophrenia patients and their association to a clinical response. NPJ Schizophr 1:15050. \nhttps:\/\/doi.org\/10.1038\/npjschz.2015.50","journal-title":"NPJ Schizophr"},{"key":"1002_CR4","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/14789450.2016.1252262","volume":"13","author":"S Sabherwal","year":"2016","unstructured":"Sabherwal S, English JA, F\u00f6cking M, Cagney G, Cotter DR (2016) Blood biomarker discovery in drug-free schizophrenia: the contribution of proteomics and multiplex immunoassays. Expert Rev Proteomics 13:1141\u20131155","journal-title":"Expert Rev Proteomics"},{"key":"1002_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12031-018-1165-4","volume":"66","author":"ZL Bai","year":"2018","unstructured":"Bai ZL, Li XS, Chen GY et al (2018) Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia. J Mol Neurosci 66:428\u2013436","journal-title":"J Mol Neurosci"},{"key":"1002_CR6","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1038\/tp.2012.3","volume":"2","author":"E Schwarz","year":"2012","unstructured":"Schwarz E, Guest PC, Steiner J, Bogerts B, Bahn S (2012) Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients. Transl Psychiatry 2:e82. \nhttps:\/\/doi.org\/10.1038\/tp.2012.3","journal-title":"Transl Psychiatry"},{"key":"1002_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fpsyt.2018.00580","volume":"9","author":"J Suvisaari","year":"2018","unstructured":"Suvisaari J, Mantere O, Kein\u00e4nen J et al (2018) Is it possible to predict the future in first-episode. Psychosis? Front Psychiatry 9:580. \nhttps:\/\/doi.org\/10.3389\/fpsyt.2018.00580","journal-title":"Front Psychiatry"},{"issue":"1","key":"1002_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41398-018-0366-5","volume":"9","author":"E Martinuzzi","year":"2019","unstructured":"Martinuzzi E, Barbosa S, Daoudlarian D et al (2019) Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study. Transl Psychiatry 9(1):20. \nhttps:\/\/doi.org\/10.1038\/s41398-018-0366-5","journal-title":"Transl Psychiatry"},{"key":"1002_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fpsyt.2018.00209","volume":"9","author":"A Aquino","year":"2018","unstructured":"Aquino A, Alexandrino GL, Guest PC et al (2018) Blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients. Front Psychiatry 9:209. \nhttps:\/\/doi.org\/10.3389\/fpsyt.2018.00209","journal-title":"Front Psychiatry"},{"key":"1002_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-319-52479-5_15","volume-title":"Proteomic methods in neuropsychiatric research","author":"S Garcia","year":"2017","unstructured":"Garcia S, Silva-Costa LC, Reis-de-Oliveira G et al (2017) Identifying biomarker candidates in the blood plasma or serum proteome. In: Guest PC (ed) Proteomic methods in neuropsychiatric research. Springer, Cham, pp 193\u2013203"},{"key":"1002_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jprot.2012.05.027","volume":"76","author":"JA Jaros","year":"2012","unstructured":"Jaros JA, Martins de Souza D, Rahmoune H et al (2012) Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls. J Proteomics 76:43\u201355. \nhttps:\/\/doi.org\/10.1016\/j.jprot.2012.05.027","journal-title":"J Proteomics"},{"key":"1002_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, de Rivera H et al (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530:177\u2013183. \nhttps:\/\/doi.org\/10.1038\/nature16549","journal-title":"Nature"},{"key":"1002_CR13","first-page":"53","volume-title":"Complement system in neural synapse elimination in development and disease","author":"J Presumey","year":"2017","unstructured":"Presumey J, Bialas AR, Carroll MC (2017) Complement system in neural synapse elimination in development and disease. Elsevier, Amsterdam pp\u00a053\u201379"},{"key":"1002_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/mp.2016.220","volume":"22","author":"CM Sellgren","year":"2016","unstructured":"Sellgren CM, Sheridan SD, Gracias J et al (2016) Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors. Mol Psychiatry 22:170\u2013177. \nhttps:\/\/doi.org\/10.1038\/mp.2016.220","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1002_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/schbul\/sbx075","volume":"44","author":"JA English","year":"2018","unstructured":"English JA, Lopez LM, O\u2019Gorman A et al (2018) Blood-based protein changes in childhood are associated with increased risk for later psychotic disorder: evidence from a nested case-control study of the ALSPAC longitudinal birth cohort. Schizophr Bull 44(2):297\u2013306. \nhttps:\/\/doi.org\/10.1093\/schbul\/sbx075","journal-title":"Schizophr Bull"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-019-01002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-019-01002-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-019-01002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T23:15:53Z","timestamp":1585610153000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-019-01002-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1007\/s00406-019-01002-3","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}